| Literature DB >> 31280877 |
Ricardo Roa-Chamorro1, Lucía Torres-Quintero2, Carlos García de Los Ríos3, José Manuel Puerta-Puerta4, Pablo González-Bustos3, Juan Diego Mediavilla-García3.
Abstract
The development of cardiovascular disease appears in subjects with several cardiovascular risk factors. However, other agents could be related to the appearance of cardiovascular disease, like chemotherapy drugs. We present a 63 years-old man with very high cardiovascular risk and chronic myeloid leukemia under treatment with nilotinib. Despite a good control of cardiovascular risk factors, he development a severe and accelerated peripheral arterial disease. Peripheral arterial disease occurs in 5-20% patients under treatment with nilotinib and it is more frequently in subjects with several cardiovascular risk factors.Entities:
Keywords: Chronic myeloid leukaemia; Enfermedad arterial periférica; Leucemia mieloide crónica; Nilotinib; Peripheral arterial disease
Mesh：
Substances：
Year: 2019 PMID： 31280877 DOI： 10.1016/j.arteri.2019.05.002
Source DB: PubMed Journal: Clin Investig Arterioscler ISSN： 0214-9168